Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia

Overview of attention for article published in Nature, September 2000

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

patent: 17 patents

wikipedia: 1 Wikipedia page

Readers on

mendeley: 105 Mendeley

So far, Altmetric has seen 17 patents that reference this research output.

Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor

Grant US-11261251-B2

United States of America

01 Mar 2022

TAT PEPTIDE BINDING PROTEINS AND USES THEREOF

Application WO-2021159024-A1

World Intellectual Property Organisation (WIPO)

12 Aug 2021

HUMAN ANTI-PD-1, PD-L1, AND PD-L2 ANTIBODIES AND USES THEREOF

Application EP-3530672-A1

European Patent Office

28 Aug 2019

Human anti-PD-1, PD-L1, and PD-L2 antibodies and uses therefor

Grant US-10370448-B2

United States of America

06 Aug 2019

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 13 additional patents.